ES2160580T3 - Ensayo de la hepatitis c que utiliza antigenos recombinantes dirigidos contra la region c-100. - Google Patents

Ensayo de la hepatitis c que utiliza antigenos recombinantes dirigidos contra la region c-100.

Info

Publication number
ES2160580T3
ES2160580T3 ES92919024T ES92919024T ES2160580T3 ES 2160580 T3 ES2160580 T3 ES 2160580T3 ES 92919024 T ES92919024 T ES 92919024T ES 92919024 T ES92919024 T ES 92919024T ES 2160580 T3 ES2160580 T3 ES 2160580T3
Authority
ES
Spain
Prior art keywords
test
hepatitis
directed against
recombinant antigens
against region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92919024T
Other languages
English (en)
Inventor
Suresh M Desai
James M Casey
Kevin R Rupprecht
Sushil G Devare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2160580T3 publication Critical patent/ES2160580T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN ANTIGENO RECOMBINADO UNICO QUE REPRESENTA REGIONES ANTIGENAS FORMALES DEL GENOMA VHC EL CUAL PUEDE SER USADO PARA LA DETECCION DE ANTICUERPOS Y ANTIGENOS EN CUERPOS FLUIDOS DE INDIVIDUOS EXPUESTOS AL VIRUS DE LA HEPATITIS C (VHC). LA PRESENTE INVENCION TAMBIEN PROPORCIONA UNA PRUEBA PARA DETECTAR LA PRESENCIA DE UN ANTICUERPO PARA UN ANTIGENO DE VHC EN UNA MUESTRA, PONIENDO EN CONTACTO LA MUESTRA CON LOS ANTIGENOS RECOMBINADOS. FORMATOS PREFERIDOS DEL ENSAYO INCLUYEN UNA PRUEBA DE FILTRADO, UNA PRUEBA CONFIRMATORIA, UNA PRUEBA DE COMPETICION O NEUTRALIZACION Y UNA PRUEBA INMUNOPUNTUAL.
ES92919024T 1991-08-21 1992-08-21 Ensayo de la hepatitis c que utiliza antigenos recombinantes dirigidos contra la region c-100. Expired - Lifetime ES2160580T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74856691A 1991-08-21 1991-08-21

Publications (1)

Publication Number Publication Date
ES2160580T3 true ES2160580T3 (es) 2001-11-16

Family

ID=25009989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92919024T Expired - Lifetime ES2160580T3 (es) 1991-08-21 1992-08-21 Ensayo de la hepatitis c que utiliza antigenos recombinantes dirigidos contra la region c-100.

Country Status (6)

Country Link
EP (1) EP0600018B1 (es)
JP (1) JP3327549B2 (es)
CA (1) CA2116026C (es)
DE (1) DE69231932T2 (es)
ES (1) ES2160580T3 (es)
WO (1) WO1993004087A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322769A (en) * 1988-03-11 1994-06-21 Abbott Laboratories Methods for using CKS fusion proteins
CN109232722B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段317-325及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808536A (en) * 1986-02-27 1989-02-28 Centocor, Inc. Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines

Also Published As

Publication number Publication date
CA2116026A1 (en) 1993-03-04
JP3327549B2 (ja) 2002-09-24
EP0600018B1 (en) 2001-07-11
EP0600018A4 (en) 1995-03-01
CA2116026C (en) 2004-11-23
WO1993004087A1 (en) 1993-03-04
DE69231932T2 (de) 2002-04-04
JPH06510190A (ja) 1994-11-17
EP0600018A1 (en) 1994-06-08
DE69231932D1 (de) 2001-08-16

Similar Documents

Publication Publication Date Title
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
BR9106309A (pt) Combinacao de antigenos sinteticos de hepatite c viral (hcv),processo de detectar anticorpos para o virus da hepatite c e estojo para realizar teste
BRPI0111731C1 (pt) suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
ATE306939T1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
CO4960659A1 (es) Vacuna que comprende un antigeno de virus de la hepatitis b y un antigeno del virus herpes simplex
ES2065935T3 (es) Anticuerpos monoclonales de raton para hiv-i p24 y su uso en ensayos de diagnostico.
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
UA39944C2 (uk) Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
ES2080099T3 (es) Ensayo para la hepatitis c.
PT599417E (pt) Metodo para dissociar um imunocomplexo e imunoensaio que o utiliza
WO2003002749A3 (en) Methods for the simultaneous detection of hcv antigens and hcv antibodies
NO160474C (no) Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener.
WO2004016586A3 (en) Compositions and methods related to flavivirus envelope protein domain iii antigens
ATE303597T1 (de) Hcv mosaik antigen zusammensetzung
NO20081909L (no) Bovint viralt diare virus (BVDV), samt BVDV-vaksine
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
EP0881910A4 (en) USE OF IMMUNOCONJUGATES TO ENHANCE THE EFFICACY OF MULTI-STEP VACCINES STIMULATING IMMUNE REACTIONS IN CASCADE
ES2160580T3 (es) Ensayo de la hepatitis c que utiliza antigenos recombinantes dirigidos contra la region c-100.
HUP0201087A2 (hu) Hepatitisz-C antigén-antitest kombinációs vizsgálati eljárás a fertőzés korai kimutatására
Neralwar et al. Detection of NS1 antigen, IgM antibody for the diagnosis of dengue infection in patients with acute febrile illness
Elrefaei et al. Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt
DE69928064D1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
ATE212129T1 (de) Präsentation von aus lipoarabinomannan bestehenden antigenen an t-zellen durch cd1 moleküle
FI923020A0 (fi) Inte a inte b-sekvenser.
KR930703613A (ko) 시료 희석물중 과산화물 디스뮤타제의 용도

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 600018

Country of ref document: ES